![Giorgio Fassina](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Giorgio Fassina is the founder and current Chairman of Xeptagen SpA, which is founded in 2001.
He is also currently a Professor at Alma Mater Studiorum - Università di Bologna, where he has been working since 1995.
Dr. Fassina received a doctorate degree from the University of Padua.
Posizioni attive di Giorgio Fassina
| Società | Posizione | Inizio |
|---|---|---|
Xeptagen SpA
 Xeptagen SpA Medical SpecialtiesHealth Technology Engages in the discovery and validation of molecular biomarkers in order to produce diagnostic kits for cancer early detection, monitoring, and evaluation of response to therapy | Fondatore | 01/01/2001 |
Alma Mater Studiorum - Università di Bologna
 Alma Mater Studiorum - Università di Bologna Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1995 |
Formazione di Giorgio Fassina
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
University of Padua
 University of Padua Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alma Mater Studiorum - Università di Bologna
Alma Mater Studiorum - Università di Bologna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xeptagen SpA
Xeptagen SpA Medical SpecialtiesHealth Technology Engages in the discovery and validation of molecular biomarkers in order to produce diagnostic kits for cancer early detection, monitoring, and evaluation of response to therapy | Health Technology |
